digital global generics & biosimilars - pharma intelligence

ENTRY AND GENERAL INQUIRIES:Natalie CornwellT: +44 (0) 7827 993 776E: [email protected]

Entry GuideDigital Global Generics & Biosimilars Awards 2020

Digital Awards | November 3, 2020www.pharmaintelligence.informa.com/ggba

Digital

Entry deadline: August 14, 2020

Digital Global Generics & Biosimilars Awards 2020 | Entry Guide

ENTRY AND GENERAL INQUIRIES [email protected] | +44 (0) 7827 993 776 | www.pharmaintelligence.informa.com/ggba

Digital Awards Presentation & Entertainment

There are fourteen Award categories; entrants must formally supply supporting information for evaluation by our Expert Judging Panels. These comprise both independent Generics and Biosimilars industry experts and authorities in the disciplines involved.

There is no entry fee to enter these Awards. Entrants should simply complete the entry form(s).

Recognizing the best in the Global Generics and Biosimilars industries



Recognizing success

The Digital Global Generics & Biosimilars Awards 2020 are proud to lead the way in rewarding best practice while encouraging improvement in every aspect of the way business is conducted.

Business development initiatives – such as through innovative product development, clever licensing deals or smart legal manoeuvres – will be at the heart of the Digital Global Generics & Biosimilars Awards 2020 and industry leaders will also be rewarded.

Equally important will be recognizing the industries’ best executives and leading companies. Entries for these exciting Awards are being sought now.



Who can enter?

Why enter?

The Awards are open to any company or individual involved in developing, authorising, marketing and distributing bioequivalent generics or biosimilars.

• This is your chance to gain recognition for your hard work at an event full of industry professionals

• Credibility sells – winning this prestigious accolade is something that money can’t buy• Master your sector – our Awards cover activities across the generics and Biosimilars

industries• You don’t have to be big – just the best!

In addition, the Digital Global Generics & Biosimilars Awards are FREE to enter! You have done the hard work, now all you need to do is convince the judges you’re the best.



Categories

1. Company of the Year

2. Company of the Year, Americas

3. Company of the Year, EMEA

4. Company of the Year, Asia-Pacific

5. Acquisition of the Year

6. Leader of the Year

7. Value Added Medicine Initiative of the Year

8. Business Development of the Year

9. API Supplier of the Year

10. Biosimilar Initiative of the Year

11. Regulatory Achievement of the Year

12. Legal Strategy of the Year

13. Industry Partner of the Year

14. Corporate Social Responsibility Initiative of the Year

Awards entry deadline: August 14, 2020



Entry Criteria

Evidence cited in supporting text could include: market data to show commercial success; details of deals done, synergies delivered and integration goals achieved; brief accounts of litigation and other legal action; or responses and testimonials from customers. The activities in question should have taken place between July 1, 2019 – June 30, 2020.

Company of the YearOpen to any company that generates at least a third, or at least US$250 million, of its annual sales from generics or biosimilars.

Regional Companies of the YearOpen to any company that generates at least a third, or at least US$250 million, of its annual sales from generics and biosimilars. Qualification for a region is dependent on the headquarters (not tax domicile) of a company’s generics and/or biosimilars business.

Company of the Year – Americas Company of the Year – Asia-Pacific Company of the Year – EMEA

Acquisition of the YearOpen to any company which has acquired another company that is active in generics and/or biosimilars, or has acquired a portfolio of generic and/or biosimilar products.

Leader of the YearOpen to any member of the senior management team of a firm within the generics or biosimilars industries. Judges will want to see how the entered leaders have best applied company values within the business environment – achieving measured and sustainable growth, driving improved performance, delivering shareholder value, implementing robust strategies, engaging staff, demonstrating market knowledge and true customer insight.

Value Added Medicine Initiative of the YearEntries in this category could include known molecules that are repurposed for new indications, reformulated in a way that adds value for patients, put together in innovative combinations, or which feature added-value packaging or delivery methods.

API Supplier of the YearOpen to any company supplying off-patent active pharmaceutical ingredients (APIs) or intermediates.



Entry Criteria continued

Business Development of the YearOpen to any generics and/or biosimilars alliance, joint venture, distribution agreement, licensing deal or similar that does not involve the acquisition of another company or a portfolio of products.

Biosimilar Initiative of the YearEntries may relate to any biosimilar currently marketed, approved or in clinical development, sales and marketing initiatives, distribution agreements or other initiatives aimed at increasing biosimilar usage.

Legal Strategy of the YearThis category allows generics, biosimilars and value-added medicines firms as well as their partnering law firms to highlight outstanding results from their legal strategy. This could include notable litigation results allowing a competitive advantage or early launch; inventive ways of getting around or invalidating intellectual property; or ways in which legal strategies from different global jurisdictions have been used as a template elsewhere, showing the benefits of a co-ordinated international legal strategy.

Regulatory Achievement of the YearAwarded to identify excellence in the regulatory sphere. This could include innovative approaches to obtaining marketing authorisations, regulatory milestones for individual companies, or developments that represent a wider breakthrough for the global generics and/or biosimilars industries.

Industry Partner of the YearAwarded to recognize outstanding achievements by firms or individuals that work alongside generics and biosimilars manufacturers and suppliers. These could include logistics providers, contract-research organisations, contract-manufacturers, law firms and consultants.

Corporate Social Responsibility (CSR) Initiative of the YearHumanitarian charity International Health Partners (IHP) has partnered with Generics Bulletin to create this Award. Entries could include: company approach to CSR, implementation, engagement plans, training & education programmes, compulsory licensing and humanitarian aid donations.



1. SELECT – your category

2. CREATE – your online account here

3. COMPLETE – the online entry form explaining why you or your company should be considered a winner this year. Please refer to the category criteria to guide your entry.

4. SUBMIT – your entry and you will receive an automated submission receipt

Entry deadline: August 14, 2020

www.pharmaintelligence.informa.com/ggba

ConfidentialityWe recognize and respect the sensitive nature of the information submitted in the entries. We ensure that this recognition is shared by our Judging Panel and therefore require each judge to sign a confidentiality agreement before they are appointed. Entries are not disclosed or discussed outside the judging process. Once an entry is shortlisted, extracts from the entry summary only will be sourced for inclusion in the Awards ceremony and any subsequent editorial coverage. Please ensure your entry summary contains no confidential or sensitive information. The Judging Panel for each Award is selected to avoid any conflict of interest.

How to enter



FAQ

Q. How do I enter?A. It’s very simple. Ensure you have read the entry guidelines and category criteria. Decide which category/categories you wish to enter, and create your on-line account at https://www.eventsforce.net/informabi/71/home. Once you are ready click ‘Enter Now’, follow the onscreen instructions, saving your entry as you go, and submit your entry by clicking ‘Enter’.

Q. How much does it cost to enter?A. Entering the Digital Global Generics & Biosimilars Awards is FREE of charge.

Q. When is the entry deadline?A. Entries are being accepted until Friday 14 August, 2020.

Q. I am not sure which category our entry would fit into?A. If you are not sure which category your entry fits into, please contact Natalie Cornwell at [email protected] for further assistance.

Q. Can I enter the same submission into more than one category?A. We encourage entries in more than one category per individual or company, where appropriate; please ensure to review the category criteria and tailor your entry accordingly.

Q. How will I know whether my submission has been received?A. All submissions will be acknowledged by an automated email once you have submitted your entry. Our Awards team will also get in touch with you again shortly before the entry deadline. If you have any concerns, please contact Natalie Cornwell at [email protected]

Q. How will I know if my submission has been successful?A. Following the judging all companies and individuals will be notified by email. Finalists will be announced on our website. If you are successful, you will also receive an email from us on what happens next.

Q. Are there other ways I can get involved in the Awards?A. Yes, there are many sponsorship opportunities available. Please contact Christopher Keeling (+44 (0) 203 377 3183 or [email protected]) for information.



Thank you

Entry Deadline: Friday, 14 August, 2020

Visit https://www.eventsforce.net/informabi/71/home to start on your entry now.

Entry, ticket bookings and general inquiries:Natalie Cornwell, Event ManagerTel: +44 (0) 7827 993 776Email: [email protected]

Sponsorship inquiries:Christopher KeelingTel: +44 (0) 203 377 3183Mobile: +44 (0) 7917 647 859Email: [email protected]

digital global generics & biosimilars - pharma intelligence

Documents